Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnox M 2mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Noxin Biocare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glimnox M 2mg/1000mg Tablet SR

Diabex Duo 2mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continue taking this medication as prescribed, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms such as sweating, dizziness, headache, and trembling, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your doctor before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimnox M 2mg/1000mg Tablet SR

No text provided to rephrase.

Uses of Glimnox M 2mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimnox M 2mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimnox M 2mg/1000mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume with a meal.

Common Side effects of Glimnox M 2mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnox M 2mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Glimnox M 2mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Glimnox M 2mg/1000mg Tablet SR works:

Glimnox M 2mg/1000mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimnox M 2mg/1000mg SR tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimnox M 2mg/1000mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimnox M tablets (2mg/1000mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimnox M 2mg/1000mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glimnox M 2mg/1000mg SR tablets are contraindicated in patients exhibiting severe renal insufficiency. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnox M 2mg/1000mg Tablet SR cautiously, as dose modification may be necessary. Individuals with severe liver disease should avoid this medication. A reduced starting dose is typically advised for those with mild to moderate hepatic dysfunction. Physician consultation is recommended.

What if you forget to take Glimnox M 2mg/1000mg Tablet SR :

Should you forget a Glimnox M 2mg/1000mg SR tablet, take it immediately if you remember. Otherwise, omit the missed dose if your next scheduled intake is imminent and resume your usual dosage regimen. Never take more than the prescribed amount at one time.

Facts to Know About Glimnox M 2mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimnox M 2mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnox M 2mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimnox M 2mg/1000mg Tablet SR and seek immediate medical attention.
Glimnox M 2mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimnox M 2mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimnox M 2mg/1000mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimnox M 2mg/1000mg SR tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimnox M 2mg/1000mg SR tablets with alcohol is unsafe. Alcohol can lower your blood sugar, risking hypoglycemia, and may also increase the risk of lactic acidosis.
Glimnox M 2mg/1000mg Tabl...
113
MRP 138
18% off